within Pharmacolibrary.Drugs.D_Dermatologicals.D01A_AntifungalsForTopicalUse.D01AC05_Isoconazole;

model Isoconazole
  extends Pharmacolibrary.Drugs.ATC.D.D01AC05;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>D01AC05</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Isoconazole is an imidazole antifungal agent primarily used topically to treat cutaneous fungal infections such as dermatophytosis, candidiasis, and pityriasis versicolor. It is not approved for systemic use and is currently available as a topical preparation in some countries.</p><h4>Pharmacokinetics</h4><p>No pharmacokinetic parameters in humans after topical administration have been reported in indexed literature. Published data suggest negligible systemic absorption in healthy adult volunteers.</p><h4>References</h4><ol><li><p>Lademann, J, et al., &amp; Seifert, S (2012). Non-invasive analysis of penetration and storage of Isoconazole nitrate in the stratum corneum and the hair follicles. <i>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</i> 80(3) 615–620. DOI:<a href=&quot;https://doi.org/10.1016/j.ejpb.2011.12.013&quot;>10.1016/j.ejpb.2011.12.013</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22285524/&quot;>https://pubmed.ncbi.nlm.nih.gov/22285524</a></p></li><li><p>Dykes, PJ, et al., &amp; Täuber, U (1986). The retention of isoconazole in the skin after once or twice daily application of 1% isoconazole nitrate cream (Travogen) over a 14-day period. <i>Clinical and experimental dermatology</i> 11(4) 365–370. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2230.1986.tb00476.x&quot;>10.1111/j.1365-2230.1986.tb00476.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3802568/&quot;>https://pubmed.ncbi.nlm.nih.gov/3802568</a></p></li><li><p>Täuber, U (1987). Availability of isoconazole in human skin after dermal application as free base and as nitrate in vitro. <i>Arzneimittel-Forschung</i> 37(4) 461–463. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3606700/&quot;>https://pubmed.ncbi.nlm.nih.gov/3606700</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Isoconazole;
